New Delhi, December 24, 2019: Roche Diabetes Care (RDC) India today announced that its Accu-Chek brand of blood glucose motoring products are compliant with the revised standards of IS/ISO 15197:2013 announced by Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health & Family Welfare.
The original notification issued on 16 February 2016 stated that the revised IS/ISO 15197:2013 were to be effective after 36 months of its publication by Bureau of Indian Standards (BIS), which was stated to be October, 19, 2016. Given the 36-month period of transition the effective date for the implementation of IS/ISO 15197:2013 is now 18 October 2019.
Using products that comply with the above mentioned standards will give confidence to people with diabetes that their meter gives most accurate readings of their blood glucose level, thereby enabling better management of their condition.
Corporate Comm India(CCI Newswire)
By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…
Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…
New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…
National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…
Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…
New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…